Brawn Biotech Ltd
₹0.00▲ +0.00 (+0.00%)
530207·NSE·Healthcare
Market Cap
7.10 Cr
PE Ratio
7.50
Volume
—
Day High - Low
—
52W High-Low
24.37 - 16.66
₹0.00▲ +0.00 (+0.00%)
Market Cap7.10 Cr
PE Ratio7.50
Volume—
Day High - Low—
52W High-Low24.37 - 16.66
Brawn Biotech Ltd (530207): company summary
Brawn Biotech Ltd (530207) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.
Brawn Biotech Ltd (530207) is a micro-cap Healthcare company valued at ₹7 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -8.6% a year over three years. Return on equity is 24.4%.
- Valuation multiples
- The stock trades at 7.5 times earnings, a discount to the Healthcare median of 32.5, 1.62 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.0/10
Weak
Fair Value
Sign in to see
ROE
24.40%
Strong
P/E
7.50x
Cheap
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹16.66
₹24.37
DocStoX take
Supported by valuation (9.0), but held back by growth (1.5). Valuation looks strong at 9.0, but that is offset by growth at 1.5 and quality at 2.1. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.0
/10
Weak
Quality
Weak
ROE 24.4%
Valuation
Cheap
P/E 7.5×
Growth
Flat
Revenue -13.5% 5Y CAGR
Risk
Elevated
D/E 0.00
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹7 Cr
52W High / Low
₹24 / ₹17
Dividend Yield
0.00%
Promoter Holding
52.94%
EPS (TTM)
₹-5.80
Book Value
₹14.47
Key highlights
- Low leverage — D/E 0.00
- Undemanding at 8× earnings
- Strong returns on equity (24%)
- Profit shrinking 0% a year
- Revenue shrinking 13% a year
3 Positives4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Brawn Biotech Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Brawn Biotech Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Brawn Biotech Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing